Last reviewed · How we verify
NCT05833646
Comparison of the Effects of ShotBlocker, Virtual Reality Glasses and Cold Application in Subcutaneous Heparin Injection
NA trial testing Group 1 in Subcutaneous Injection in 150 participants. Completed in 25 July 2023.
15 March 2023
Quick facts
| Lead sponsor | Ankara Yildirim Beyazıt University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 1 March 2023 |
| Primary completion | 15 March 2023 |
| Estimated completion | 25 July 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Group 1
- Group 2
- Group 3
Conditions studied
- Subcutaneous Injection — all drugs for Subcutaneous Injection →
Sponsor
Ankara Yildirim Beyazıt University
Who can join
18 and older, any sex, with Subcutaneous Injection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to compare the effects of ShotBlocker, virtual reality glasses and cold application on pain and patient satisfaction in patients who were applied subcutaneous low molecular weight heparin (LMWH) injection in adult patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05833646
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Group 1
Trials testing the same drug.
- NCT07169006 — The Effect of Preoperative Gabapentin on Postoperative Pain Control and Analgesic Requirements Following Bariatric Surge · NA · not yet recruiting
- NCT07526935 — Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator · NA · active not recruiting
- NCT06685263 — Development of Perioperative Delirium Prediction Model · not yet recruiting
- NCT06652555 — The Incidence and Risk Factors of Central Nervous System Adverse Events of Lorlatinib in Patients with ALK-positive Adva · not yet recruiting
- NCT06617507 — The Effect of Selective Dorsal Rhizotomy Surgery on Walking in Children With Ambulatory Cerebral Palsy in Turkey · completed
Other Ankara Yildirim Beyazıt University trials
Trials by the same sponsor.
- NCT07530835 — Occlusal Changes After Modified Hall Technique in Molars Affected by Molar-Incisor Hypomineralization · NA · not yet recruiting
- NCT07496853 — Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke · NA · recruiting
- NCT07441668 — Comfort Intervention in PICU Children · NA · not yet recruiting
- NCT07431151 — Effects of Intensive Virtual Reality-Based Balance and Gait Training on Activity Performance and Quality of Life in Suba · NA · recruiting
- NCT07247903 — The Impact of Patient Education Delivered Through Virtual Reality · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05833646 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Yildirim Beyazıt University
- Last refreshed: 1 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05833646.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing